Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,511 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    First Class Action Involving A Prescription Drug Being Denied Certification In British Columbia?

    In Charlton v. Abbott Laboratories, Ltd., 2015 BCCA 26, the Court of Appeal for British Columbia overturned certification of a class action on behalf of all Canadian consumers of sibutramine, a weight-loss drug.
    CanadaFood, Drugs, Healthcare, Life Sciences
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Food And Beverage M&A Landscape: Trends To Watch

    Following the sky-high activity from 2021, M&A activity in the food and beverage industry slowed to more sustainable levels in 2022, inching closer to 2019 numbers in terms of deal volume and value.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Blake, Cassels & Graydon LLP
Blake, Cassels & Graydon LLP
  • Article

    Front-Of-package Labelling Deadline Fast Approaching For Prepackaged Foods

    Canada's new front-of-package (FOP) nutrition symbol labelling requirements are less than a year away. By January 1, 2026, many pre-packaged food products that meet or exceed prescribed thresholds for sodium...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Government Liability For Unnecessary Product Recall

    In the recent decision, the British Columbia Court of Appeal addressed the issue of liability on the part of a Canadian government regulator for damages arising out of negligent performance of its duties where the performance of those duties led to a recall of the plaintiff's product.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Health Canada Announces Changes To The Cannabis Licensing Process

    On May 8, 2019, Health Canada published a statement concerning changes to the licensing process for cannabis.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Langlois Avocats
    Langlois Avocats
  • Article

    Health Canada Improvements To The Licensing Of Cannabis Production Under The ACMPR

    On May 26, 2017, Health Canada announced significant developments to the licensing process under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Cassels
    Cassels
  • Article

    Health Canada Proposes Restrictions On Advertising Food To Children

    On Oct. 24, 2016, Minister of Health Jane Philpott announced that Health Canada will be implementing restrictions on advertising and marketing aimed at children.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Health Canada Provides Clarifications On Application Of The Definition Of Canadian Reference Product Based On Dormant Status

    We previously reported Health Canada's March 27, 2023 consultation on its proposed application of the definition of Canadian reference product (CRP) based on "Dormant Status" under s. C.08.001.1(b)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Releases Its Health Product Highlights, Annual Drug Submission Performance Reports And OPML Statistical Report

    Health Canada released a number of reports over the summer: Annual Health Product Highlights for 2021, which provides an overview of new health products, including drugs and medical devices...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Releases Updated Warnings About Elmiron Related Vision Loss

    Health Canada released a Dear Health Professional Letter on December 15, 2020 to advise healthcare professionals, including urologists, urogynecologists...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Siskinds LLP
    Siskinds LLP
  • Article

    Health Canada Seeks Feedback On Phased Implementation Of The Incorporated By Reference List For Ministerial Reliance Order

    As previously reported, Health Canada has proposed a Ministerial Reliance Order that would allow Health Canada to rely on decisions of foreign regulatory authorities (FRAs). Health Canada has proposed that the Reliance Order will come into force in summer 2026, at which point Health Canada will consult on an applicable guidance document.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Healthy Menu Choices: Practice Points, Part 2

    As we previously reported, the Healthy Menu Choices Act, 2015 came into force on January 1, 2017.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Impact Of Cannabis On The Insurance Industry

    With the legalization of recreational cannabis and regulations for edibles soon to come, Field Law's Cannabis Group has the knowledge and experience to help clients, including those in the insurance industry, understand how cannabis laws impact them.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Field Law
    Field Law
  • Article

    Important Changes To Applications For Federal Cannabis Licences

    Health Canada has introduced new eligibility requirements, effective immediately, for three classes of cannabis licences: cultivation, processing and sale for medical purposes.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

    L'Alliance pharmaceutique pancanadienne (« APP ») a récemment annoncé qu'elle officialisait et lançait son processus de négociation ciblé (« PNC ») révisé.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Legal Marijuana in BC – How is it Going to Work?

    Legal Marijuana in B.C. – On February 5, 2018, the B.C. government announced its plan for the distribution of recreational marijuana once it becomes legal later this year.
    CanadaFood, Drugs, Healthcare, Life Sciences
    EKB | Edwards, Kenny & Bray LLP
    EKB | Edwards, Kenny & Bray LLP
  • Article

    M&A And Cannabis-Related Matters

    As one of the members of the Aird & Berlis Cannabis Group who deals with a lot of M&As, I thought that I may have something useful to add to the conversation about mergers and acquisitions within the cannabis industry.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Aird & Berlis LLP
    Aird & Berlis LLP
  • Article

    Magic Moment: An Exemption To The Controlled Drugs And Substances Act Granted

    On August 4, 2020, it was announced that a legal exemption from the Controlled Drugs and Substances Act (CDSA) was granted to four Canadians with incurable cancer.
    CanadaFood, Drugs, Healthcare, Life Sciences
    MLT Aikins LLP
    MLT Aikins LLP
  • Article

    Medical Marijuana And Benefit Plan Coverage

    As discussed at our April A.M. Pension webinar, the Nova Scotia Court of Appeal recently released its decision in Canadian Elevator Industry Welfare Trust Fund v. Skinner.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Miller Thomson
    Miller Thomson
  • Article

    Modifications Aux Modalités De Vente De Médicaments

    L'Office des professions du Québec invite les personnes intéressées à soumettre leurs commentaires au sujet de ce projet de règlement avant le 29 juin 2020.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Showing 641–660 of 3511 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics